Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer

Name: Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
Creator: ClinicalTrials.gov
Published: 2026-07-12T01:58:48+08:00

DataMed2026-07-12 收录

HER-2阳性乳腺癌靶向治疗

临床试验药物组合

数据链接：

https://datamed.org/dataset/18f9ab51-1941-4b49-a669-20fb907da981 数据链接链接失效反馈

官方服务：

资源简介：

Phase II Pilot Study of Trastuzumab Biosimilar (Herzuma®) plus Gedatolisib in Patients with HER-2 Positive Metastatic Breast Cancer Who Progressed after 2 or more HER-2 directed Chemotherapy

提供机构：

ClinicalTrials.gov

Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer

资源简介：

相关数据集